FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3085000166> ?p ?o ?g. }

• W3085000166 endingPage "S100" @default.
• W3085000166 startingPage "S100" @default.
• W3085000166 abstract "This study evaluated the cost-effectiveness of 6 recommended treatment strategies for the patients with Chronic obstructive pulmonary disease (COPD) in China. A Markov model was developed to simulate the progression of COPD under different treatment strategies during lifetime by 3-month cycle. Key treatment adverse events were also modeled, including death, acute hospital exacerbation, acute complications and chronic complications. Model was stratified by COPD severity (mild, moderately severe and very severe). The transition probabilities, clinical inputs and the utility values were extracted from the updated information of UK NICE COPD guideline (NG115). The cost data of Chinese COPD patients were extracted from a proprietary Chinese hospital database which contains both outpatient and inpatient data from more than 3000 major hospitals in China (ADEN). During the simulation, both costs and utilities were annually depreciated at the rate of 3.5%. The model was also validated against the observed values from ADEN to assure validity. Consistently with other countries, O5 strategy [LABA(Long acting β2 receptor agonist)+ICS(Inhaled corticosteroid) followed by Triple treatment] is shown as the most effective treatment strategy, offering the most quality adjusted life years among all tested strategies for most people. Due to the lower costs associated with LABA + ICS in China, O2 strategy [LAMA(Long acting anticholinergic antagonist) followed by LABA+ICS followed by Triple treatment] could be more cost effective for young and mild patients. The key model results predicted on the population level were close to the averages of respective observed values of COPD patients (N=14,162,347) on ADEN: 5-year death rate (21.51% vs. 19.68%), annual hospital exacerbation rate (16.10% vs. 16.59%), and annual inpatient costs (RMB 10,697.59 vs. 9,384.04). O5 strategy is the most effective treatment strategy for most Chinese COPD patients, while O2 strategy could be more cost effective for young and mild patients." @default.
• W3085000166 created "2020-09-21" @default.
• W3085000166 creator A5026912537 @default.
• W3085000166 creator A5049456441 @default.
• W3085000166 creator A5087195866 @default.
• W3085000166 date "2020-09-01" @default.
• W3085000166 modified "2023-10-01" @default.
• W3085000166 title "PRS8 The Cost Effectiveness Analysis of SIX COPD Treatment Strategies in China" @default.
• W3085000166 doi "https://doi.org/10.1016/j.vhri.2020.07.522" @default.
• W3085000166 hasPublicationYear "2020" @default.
• W3085000166 type Work @default.
• W3085000166 sameAs 3085000166 @default.
• W3085000166 citedByCount "0" @default.
• W3085000166 crossrefType "journal-article" @default.
• W3085000166 hasAuthorship W3085000166A5026912537 @default.
• W3085000166 hasAuthorship W3085000166A5049456441 @default.
• W3085000166 hasAuthorship W3085000166A5087195866 @default.
• W3085000166 hasBestOaLocation W30850001661 @default.
• W3085000166 hasConcept C126322002 @default.
• W3085000166 hasConcept C142724271 @default.
• W3085000166 hasConcept C159110408 @default.
• W3085000166 hasConcept C177713679 @default.
• W3085000166 hasConcept C1862650 @default.
• W3085000166 hasConcept C194828623 @default.
• W3085000166 hasConcept C2776719499 @default.
• W3085000166 hasConcept C2776780178 @default.
• W3085000166 hasConcept C2777014857 @default.
• W3085000166 hasConcept C2779951463 @default.
• W3085000166 hasConcept C2780182762 @default.
• W3085000166 hasConcept C2780911369 @default.
• W3085000166 hasConcept C71924100 @default.
• W3085000166 hasConceptScore W3085000166C126322002 @default.
• W3085000166 hasConceptScore W3085000166C142724271 @default.
• W3085000166 hasConceptScore W3085000166C159110408 @default.
• W3085000166 hasConceptScore W3085000166C177713679 @default.
• W3085000166 hasConceptScore W3085000166C1862650 @default.
• W3085000166 hasConceptScore W3085000166C194828623 @default.
• W3085000166 hasConceptScore W3085000166C2776719499 @default.
• W3085000166 hasConceptScore W3085000166C2776780178 @default.
• W3085000166 hasConceptScore W3085000166C2777014857 @default.
• W3085000166 hasConceptScore W3085000166C2779951463 @default.
• W3085000166 hasConceptScore W3085000166C2780182762 @default.
• W3085000166 hasConceptScore W3085000166C2780911369 @default.
• W3085000166 hasConceptScore W3085000166C71924100 @default.
• W3085000166 hasLocation W30850001661 @default.
• W3085000166 hasOpenAccess W3085000166 @default.
• W3085000166 hasPrimaryLocation W30850001661 @default.
• W3085000166 hasRelatedWork W1978606330 @default.
• W3085000166 hasRelatedWork W2098608506 @default.
• W3085000166 hasRelatedWork W2355556544 @default.
• W3085000166 hasRelatedWork W2398678351 @default.
• W3085000166 hasRelatedWork W2550205988 @default.
• W3085000166 hasRelatedWork W2554782823 @default.
• W3085000166 hasRelatedWork W2885268879 @default.
• W3085000166 hasRelatedWork W2983204124 @default.
• W3085000166 hasRelatedWork W333419345 @default.
• W3085000166 hasRelatedWork W1893831803 @default.
• W3085000166 hasVolume "22" @default.
• W3085000166 isParatext "false" @default.
• W3085000166 isRetracted "false" @default.
• W3085000166 magId "3085000166" @default.
• W3085000166 workType "article" @default.